TITLE

Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer

PUB. DATE
January 2009
SOURCE
Radiation Oncology;2009, Vol. 4, p24
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
43606338

 

Related Articles

  • Early distant relapse after optimal local control in locally advanced rectal cancer. Gallego-Plazas, Javier; Menarguez-Pina, Francisco; Martinez-Banaclocha, Natividad; Pons-Sanz, Vanesa; Mingol-Navarro, Fernando; Ruiz-Macia, Jose A.; Macia-Escalante, Sonia // International Seminars in Surgical Oncology;2008, Vol. 5, Special section p1 

    We present a case of locally advanced rectal cancer with initial optimal local control after neoadjuvant concurrent chemoradiotherapy followed by surgery; early liver recurrence then occurred and was treated again with curative intent with neoadjuvant combination chemotherapy followed by liver...

  • Neoadjuvant regimen prolonged OS in late-stage nasopharyngeal cancer.  // Hem/Onc Today;10/10/2013, Vol. 14 Issue 19, p3 

    The article reports that a study has found that neoadjuvant chemotherapy followed by concurrent chemoradiation seems safe and effective in patients with locally advanced nasopharyngeal cancer.

  • Erratum: Role of Scintimammography in Assessing the Response of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.  // World Journal of Nuclear Medicine;Jan-Apr2016, Vol. 15 Issue 1, p75 

    A correction to the article "Role of Scintimammography in Assessing the Response of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer" that was published in the 2014 issue is presented.

  • Long Term Complete Response of Unresectable Locally Advanced Pancreatic Cancer after CCRT and Gemcitabine Chemotherapy. Jaeyun Yang; Taekyu Lim; Taegyoon Kim; Seungmoon Han; Sanghee Lee; Huiseo Kim; Jiwon Lee; Seongyeong Ahn // Korean Journal of Pancreas & Biliary Tract;Oct2016, Vol. 21 Issue 4, p209 

    Locally advanced or metastatic disease accounts for two thirds of total patients with pancreatic cancer. Patients with pancreatic cancer are assessed as resectable, potentially resectable (borderline) or unresectable according to pre-operative examinations. The chances of resectability may be...

  • Recent advances in multidisciplinary approach for rectal cancer. Oki, Eiji; Ando, Koji; Kasagi, Yuta; Zaitsu, Yoko; Sugiyama, Masahiko; Nakashima, Yuichiro; Sonoda, Hideto; Ohgaki, Kippei; Saeki, Hiroshi; Maehara, Yoshihiko // International Journal of Clinical Oncology;Aug2015, Vol. 20 Issue 4, p641 

    Surgery is a major treatment option for rectal cancer, and total mesorectal excision has been demonstrated to be advantageous in terms of oncological outcome and thus has been the standard surgical approach. Radiotherapy before or after radical surgery is the optimal treatment to control local...

  • Current definition of locally advanced breast cancer. Garg, Pankaj Kumar; Prakash, Gaurav // Current Oncology;Oct2015, Vol. 22 Issue 5, pe409 

    A letter to the editor is presented in response to the article "Concurrent chemoradiotherapy for locally advanced breast cancer-time for a new paradigm?" by V. Mandilaras and colleagues in the 2015 issue.

  • Response to: "Current definition of locally advanced breast cancer". Brackstone, Muriel // Current Oncology;Oct2015, Vol. 22 Issue 5, pe411 

    A response from the authors of the article "Concurrent chemoradiotherapy for locally advanced breast cancer-time for a new paradigm?" in the 2015 issue is presented.

  • Concurrent chemoradiotherapy for locally advanced breast cancer—time for a new paradigm? Mandilaras, V.; Bouganim, N.; Spayne, J.; Dent, R.; Arnaout, A.; Boileau, J. F.; Brackstone, M.; Meterissian, S.; Clemons, M. // Current Oncology;Feb2015, Vol. 22 Issue 1, p25 

    Background In cases of locally advanced breast cancer (LABC), preoperative ("neoadjuvant") therapy was traditionally reserved to render the patient operable. More recently, neoadjuvant therapy, particularly chemotherapy, is being used in patients with operable disease to increase the opportunity...

  • Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy. Cedeño, Heidy; Araúz, Rafael; Cebamanos, Fernando; De Torraza, Idalmis; Porcell, Ana // BMC Cancer;2007 Supplement 1, Vol. 7, pA50 

    An abstract of the article "Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy," by Heidy is presented.

  • Prospective Feasibility Study to Evaluate Neoadjuvant-synchronous S-1 + RT for Locally Advanced Rectal Cancer: A Multicenter Phase II Trial (UMIN ID: 03396). Inomata, Masafumi; Akagi, Tomonori; Nakajima, Kentaro; Etoh, Tsuyoshi; Shiraishi, Norio; Tahara, Koichiro; Matsumoto, Toshifumi; Kinoshita, Tadahiko; Fujii, Kyuzo; Shiromizu, Akio; Kubo, Nobuhiro; Kitano, Seigo // Japanese Journal of Clinical Oncology;Mar2013, Vol. 43 Issue 3, p321 

    In Western countries, the standard treatment for locally advanced rectal cancer is preoperative chemoradiotherapy followed by total mesorectal excision. However, in Japan, the treatment results without preoperative chemoradiotherapy are by no means inferior; therefore, extrapolation of the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics